These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 20822184)

  • 21. Synthesis of 2-(pyridin-3-yl)-1-azabicyclo[3.2.2]nonane, 2-(pyridin-3-yl)-1-azabicyclo[2.2.2]octane, and 2-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, a class of potent nicotinic acetylcholine receptor-ligands.
    Bhatti BS; Strachan JP; Breining SR; Miller CH; Tahiri P; Crooks PA; Deo N; Day CS; Caldwell WS
    J Org Chem; 2008 May; 73(9):3497-507. PubMed ID: 18363376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. From pyrrolidinyl-benzodioxane to pyrrolidinyl-pyridodioxanes, or from unselective antagonism to selective partial agonism at α4β2 nicotinic acetylcholine receptor.
    Bolchi C; Bavo F; Gotti C; Fumagalli L; Fasoli F; Binda M; Mucchietto V; Sciaccaluga M; Plutino S; Fucile S; Pallavicini M
    Eur J Med Chem; 2017 Jan; 125():1132-1144. PubMed ID: 27810599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel acetylcholine and carbamoylcholine analogues: development of a functionally selective alpha4beta2 nicotinic acetylcholine receptor agonist.
    Hansen CP; Jensen AA; Christensen JK; Balle T; Liljefors T; Frølund B
    J Med Chem; 2008 Dec; 51(23):7380-95. PubMed ID: 18989912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel 5-substituted 3-hydroxyphenyl and 3-nitrophenyl ethers of S-prolinol as α4β2-nicotinic acetylcholine receptor ligands.
    Bolchi C; Bavo F; Fumagalli L; Gotti C; Fasoli F; Moretti M; Pallavicini M
    Bioorg Med Chem Lett; 2016 Dec; 26(23):5613-5617. PubMed ID: 27818109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [¹²⁵I]AT-1012, a new high affinity radioligand for the α3β4 nicotinic acetylcholine receptors.
    Wu J; Perry DC; Bupp JE; Jiang F; Polgar WE; Toll L; Zaveri NT
    Neuropharmacology; 2014 Feb; 77():193-9. PubMed ID: 24095990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2-, 5-, and 6-Halo-3-(2(S)-azetidinylmethoxy)pyridines: synthesis, affinity for nicotinic acetylcholine receptors, and molecular modeling.
    Koren AO; Horti AG; Mukhin AG; Gündisch D; Kimes AS; Dannals RF; London ED
    J Med Chem; 1998 Sep; 41(19):3690-8. PubMed ID: 9733494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional responses and subunit composition of presynaptic nicotinic receptor subtypes explored using the novel agonist 5-iodo-A-85380.
    Mogg AJ; Jones FA; Pullar IA; Sharples CG; Wonnacott S
    Neuropharmacology; 2004 Nov; 47(6):848-59. PubMed ID: 15527819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and biological evaluation of novel hybrids of highly potent and selective α4β2-Nicotinic acetylcholine receptor (nAChR) partial agonists.
    Zhang HK; Eaton JB; Fedolak A; Gunosewoyo H; Onajole OK; Brunner D; Lukas RJ; Yu LF; Kozikowski AP
    Eur J Med Chem; 2016 Nov; 124():689-697. PubMed ID: 27639361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determinants for α4β2 vs. α3β4 Subtype Selectivity of Pyrrolidine-Based nAChRs Ligands: A Computational Perspective with Focus on Recent cryo-EM Receptor Structures.
    Bavo F; Pallavicini M; Appiani R; Bolchi C
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34204637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selectivity of ABT-089 for alpha4beta2* and alpha6beta2* nicotinic acetylcholine receptors in brain.
    Marks MJ; Wageman CR; Grady SR; Gopalakrishnan M; Briggs CA
    Biochem Pharmacol; 2009 Oct; 78(7):795-802. PubMed ID: 19481067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epibatidine analogues as selective ligands for the alpha(x)beta2-containing subtypes of nicotinic acetylcholine receptors.
    Huang Y; Zhu Z; Xiao Y; Laruelle M
    Bioorg Med Chem Lett; 2005 Oct; 15(19):4385-8. PubMed ID: 16039849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemistry, pharmacology, and behavioral studies identify chiral cyclopropanes as selective α4β2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile. Part II.
    Zhang HK; Yu LF; Eaton JB; Whiteaker P; Onajole OK; Hanania T; Brunner D; Lukas RJ; Kozikowski AP
    J Med Chem; 2013 Jul; 56(13):5495-504. PubMed ID: 23734673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and synthesis of a series of 6-substituted-2-pyridinylmethylamine derivatives as novel, high-affinity, selective agonists at 5-HT1A receptors.
    Vacher B; Bonnaud B; Funes P; Jubault N; Koek W; Assié MB; Cosi C
    J Med Chem; 1998 Dec; 41(25):5070-83. PubMed ID: 9836623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Competition, Selectivity and Efficacy of Analogs of A-84543 for Nicotinic Acetylcholine Receptors with Repositioning of Pyridine Nitrogen.
    Ogunjirin AE; Fortunak JM; Brown LL; Xiao Y; Dávila-García MI
    Neurochem Res; 2015 Oct; 40(10):2131-42. PubMed ID: 26508288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and nicotinic acetylcholine receptor in vivo binding properties of 2-fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine: a new positron emission tomography ligand for nicotinic receptors.
    Doll F; Dolci L; Valette H; Hinnen F; Vaufrey F; Guenther I; Fuseau C; Coulon C; Bottlaender M; Crouzel C
    J Med Chem; 1999 Jun; 42(12):2251-9. PubMed ID: 10377231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, Nicotinic Acetylcholine Receptor Binding, and in Vitro and in Vivo Pharmacological Properties of 2'-Fluoro-(substituted thiophenyl)deschloroepibatidine Analogues.
    Ondachi PW; Castro AH; Sherman B; Luetje CW; Damaj MI; Mascarella SW; Navarro HA; Carroll FI
    ACS Chem Neurosci; 2017 Jan; 8(1):115-127. PubMed ID: 27726337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and evaluation of a novel series of 2-chloro-5-((1-methyl-2-(S)-pyrrolidinyl)methoxy)-3-(2-(4-pyridinyl)vinyl)pyridine analogues as potential positron emission tomography imaging agents for nicotinic acetylcholine receptors.
    Brown LL; Kulkarni S; Pavlova OA; Koren AO; Mukhin AG; Newman AH; Horti AG
    J Med Chem; 2002 Jun; 45(13):2841-9. PubMed ID: 12061886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual Nicotinic Acetylcholine Receptor α4β2 Antagonists/α7 Agonists: Synthesis, Docking Studies, and Pharmacological Evaluation of Tetrahydroisoquinolines and Tetrahydroisoquinolinium Salts.
    Crestey F; Jensen AA; Soerensen C; Magnus CB; Andreasen JT; Peters GHJ; Kristensen JL
    J Med Chem; 2018 Feb; 61(4):1719-1729. PubMed ID: 29384668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and structure-activity relationship of novel pyridyl ethers for the nicotinic acetylcholine receptor.
    Lee J; Davis CB; Rivero RA; Reitz AB; Shank RP
    Bioorg Med Chem Lett; 2000 May; 10(10):1063-6. PubMed ID: 10843217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and pharmacological characterization of nicotinic acetylcholine receptor properties of (+)- and (-)-pyrido-[3,4-b]homotropanes.
    Carroll FI; Hu X; Navarro HA; Deschamps J; Abdrakhmanova GR; Damaj MI; Martin BR
    J Med Chem; 2006 Jun; 49(11):3244-50. PubMed ID: 16722642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.